Cite
HARVARD Citation
Ogert, R. et al. (2013). Resistance-Associated Amino Acid Variants Associated with Boceprevir plus Pegylated Interferon-α2B and Ribavirin in Patients with Chronic Hepatitis C in the Sprint-1 Trial. Antiviral therapy. 18 (3), pp. 387-397. [Online].